drugset / Trial / NCT00479713

A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)

NCT00479713 ↗

Phase 3 Completed 618 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter study to evaluate the safety and efficacy of ezetimibe/simvastatin versus rosuvastatin in participants with high cholesterol.

Timeline

Start
2007-02-01
Primary completion
2008-03-01
Completion
2008-03-01

Outcome

Met primary endpoint

registry LEAST_SQUARES_MEAN Ezetemibe + Simvastatin: -27.66 (-30.27 to -25.04) percent change from baseline NCT00479713 ↗

registry analysis (unspecified test); Ezetemibe + Simvastatin vs Rosuvastatin; p <=0.001; Mean Difference (Final Values) -10.72 (95% CI -14.10 to -7.33); ANOVA NCT00479713 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg —
Comparator Rosuvastatin Small molecule 10 mg —
Subject Simvastatin Small molecule 20 mg —

Indications